Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-069908
Filing Date
2023-06-09
Accepted
2023-06-09 16:11:14
Documents
1
Period of Report
2023-06-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2318251-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2318251-5_4seq1.xml 4 4230
  Complete submission text file 0001104659-23-069908.txt   5731
Mailing Address C/O BELLEROPHON THERAPEUTICS 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827
Business Address
Bruder Scott P (Reporting) CIK: 0001411721 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 231005367

Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations